EP1824493B1 — Oral suspension comprising meloxicam
Assigned to Elanco Animal Health Ireland Ltd · Expires 2008-08-13 · 18y expired
What this patent protects
The present invention relates to an oral suspension comprising meloxicam, its preparation and its use in alleviating inflammation and pain in both acute and chronic musculo-skeletal disorders.
USPTO Abstract
The present invention relates to an oral suspension comprising meloxicam, its preparation and its use in alleviating inflammation and pain in both acute and chronic musculo-skeletal disorders.
Drugs covered by this patent
- Aldactone (spironolactone) · Generic (originally Searle/Pfizer)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.